Direct accesses
Go to main menu
Go to main content
Menu
Search the site
Contact
Careers
You are viewing the website in English
en
fr
Search the site
Who
we are
Company
Leadership
Collaborations
Diseases
we target
Diseases we target
Leber Hereditary Optic Neuropathy (LHON)
Retinitis Pigmentosa (RP)
Geographic Atrophy in Dry-AMD
Our
technologies
Technologies we are applying
Gene Therapy
Mitochondrial Targeting Sequence (MTS)
Optogenetics
Clinical development Summary
Investors
Company Overview
Financial press releases
Investor Newsletters
Events & presentations
Stock information & Financial agenda
Governance
Documentation
Media
Conferences
Year
All
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
News type
All
Regulatory
Clinical
Conferences
Corporate
Finance
General Meeting
Product candidates
Science & Technology
Other
Subject
All
General Assembly
Company and personnel
GS010 - LUMEVOQ
GS030
Technologies
Other
03 May 2020 - 07 May 2020
2020 ARVO Annual Meeting, Baltimore (MD), US – cancelled
25 Apr 2020 - 01 May 2020
2020 AAN Annual Meeting, Toronto, Canada – canceled due to COVID-19
19 Apr 2020 - 21 Apr 2020
H.C. Wainwright Global Life Sciences Conference, London, UK – cancelled
03 March 2020
GenSight Biologics announces presentation of bilateral visual recovery from GS010 (LUMEVOQ™) Phase III trials at the 46th annual meeting of NANOS
15 Apr 2020 - 17 Apr 2020
2020 Cell & Gene Meeting on the Mediterranean, Barcelona, Spain – cancelled
23 Mar 2020 - 25 Mar 2020
Bio Europe Spring, Paris, France
07 Mar 2020 - 12 Mar 2020
46th NANOS Annual Meeting, Amelia Island, Florida, US
13 Jan 2020 - 16 Jan 2020
38th Annual J.P. Morgan Healthcare Conference, San Francisco (CA), USA
22 Oct 2019 - 25 Oct 2019
ESGCT 27th Annual Congress, Barcelona (Spain)
17 Oct 2019 - 19 Oct 2019
EVER 2019, Nice (FR)
View previous 9 articles
1
2
3
4
5
6
7
8
9
10
11
12
View next 9 articles
Go back to the page of the page